Expression of prolactin and its receptor in human lymphoid cells. I Pellegrini, JJ Lebrun, S Ali, PA Kelly Molecular Endocrinology 6 (7), 1023-1031, 1992 | 372 | 1992 |
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells JM Boutin, M Edery, M Shirota, C Jolicoeur, L Lesueur, S Ali, D Gould, ... Molecular Endocrinology 3 (9), 1455-1461, 1989 | 360 | 1989 |
Expression of two forms of prolactin receptor in rat ovary and liver M Shirota, D Banville, S Ali, C Jolicoeur, JM Boutin, M Edery, J Djiane, ... Molecular Endocrinology 4 (8), 1136-1143, 1990 | 302 | 1990 |
Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. L Lesueur, M Edery, S Ali, J Paly, PA Kelly, J Djiane Proceedings of the National Academy of Sciences 88 (3), 824-828, 1991 | 270 | 1991 |
Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. JJ Lebrun, S Ali, L Sofer, A Ullrich, PA Kelly Journal of Biological Chemistry 269 (19), 14021-14026, 1994 | 261 | 1994 |
Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP H Valderrama-Carvajal, E Cocolakis, A Lacerte, EH Lee, G Krystal, S Ali, ... Nature cell biology 4 (12), 963-969, 2002 | 260 | 2002 |
A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. S Ali, I Pellegrini, PA Kelly Journal of Biological Chemistry 266 (30), 20110-20117, 1991 | 234 | 1991 |
Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction JJ Lebrun, S Ali, A Ullrich, PA Kelly Journal of Biological Chemistry 270 (18), 10664-10670, 1995 | 204 | 1995 |
A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo H Jallal, ML Valentino, G Chen, F Boschelli, S Ali, SA Rabbani Cancer research 67 (4), 1580-1588, 2007 | 198 | 2007 |
PTP1D is a positive regulator of the prolactin signal leading to beta‐casein promoter activation. S Ali, Z Chen, JJ Lebrun, W Vogel, A Kharitonenkov, PA Kelly, A Ullrich The EMBO journal 15 (1), 135-142, 1996 | 167 | 1996 |
The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin E Cocolakis, S Lemay, S Ali, JJ Lebrun Journal of Biological Chemistry 276 (21), 18430-18436, 2001 | 160 | 2001 |
Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells Z Nouhi, N Chughtai, S Hartley, E Cocolakis, JJ Lebrun, S Ali Cancer research 66 (3), 1824-1832, 2006 | 150 | 2006 |
A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. JJ Lebrun, S Ali, V Goffin, A Ullrich, PA Kelly Proceedings of the National Academy of Sciences 92 (9), 4031-4035, 1995 | 149 | 1995 |
Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion M Dai, AA Al-Odaini, N Fils-Aimé, MA Villatoro, J Guo, A Arakelian, ... Breast cancer research 15, 1-14, 2013 | 122 | 2013 |
SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor S Ali, Z Nouhi, N Chughtai, S Ali Journal of Biological Chemistry 278 (52), 52021-52031, 2003 | 115 | 2003 |
Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the β-casein gene promoter in mammary cells N Chughtai, S Schimchowitsch, JJ Lebrun, S Ali Journal of Biological Chemistry 277 (34), 31107-31114, 2002 | 115 | 2002 |
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling P Minoo, MM Zadeh, R Rottapel, JJ Lebrun, S Ali Blood 103 (4), 1398-1407, 2004 | 103 | 2004 |
Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction A Kharitonenkov, J Schnekenburger, Z Chen, P Knyazev, S Ali, E Zwick, ... Journal of Biological Chemistry 270 (49), 29189-29193, 1995 | 99 | 1995 |
Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways S Ali, S Ali Journal of Biological Chemistry 273 (13), 7709-7716, 1998 | 91 | 1998 |
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells J Tian, FA Raffa, M Dai, A Moamer, B Khadang, IY Hachim, K Bakdounes, ... British journal of cancer 119 (12), 1495-1507, 2018 | 90 | 2018 |